A citation-based method for searching scientific literature

Jacqueline Lehmann-Che, Cecile Bally, Hugues de Thé. N Engl J Med 2014
Times Cited: 77







List of co-cited articles
399 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Resistance to arsenic therapy in acute promyelocytic leukemia.
Hong-Hu Zhu, Ya-Zhen Qin, Xiao-Jun Huang. N Engl J Med 2014
69
39

Diagnostic clinical genome and exome sequencing.
Leslie G Biesecker, Robert C Green. N Engl J Med 2014
72
37

Retinoic acid and arsenic trioxide for acute promyelocytic leukemia.
Francesco Lo-Coco, Giuseppe Avvisati, Marco Vignetti, Christian Thiede, Sonia Maria Orlando, Simona Iacobelli, Felicetto Ferrara, Paola Fazi, Laura Cicconi, Eros Di Bona,[...]. N Engl J Med 2013
822
25

Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML.
Xiao-Wei Zhang, Xiao-Jing Yan, Zi-Ren Zhou, Fei-Fei Yang, Zi-Yu Wu, Hong-Bin Sun, Wen-Xue Liang, Ai-Xin Song, Valérie Lallemand-Breitenbach, Marion Jeanne,[...]. Science 2010
484
24

PML/RARA oxidation and arsenic binding initiate the antileukemia response of As2O3.
Marion Jeanne, Valérie Lallemand-Breitenbach, Omar Ferhi, Marcel Koken, Morgane Le Bras, Stéphanie Duffort, Laurent Peres, Caroline Berthier, Hassane Soilihi, Brian Raught,[...]. Cancer Cell 2010
202
22

Missense mutations in PML-RARA are critical for the lack of responsiveness to arsenic trioxide treatment.
Emi Goto, Akihiro Tomita, Fumihiko Hayakawa, Akihide Atsumi, Hitoshi Kiyoi, Tomoki Naoe. Blood 2011
70
24


Activation of a promyelocytic leukemia-tumor protein 53 axis underlies acute promyelocytic leukemia cure.
Julien Ablain, Kim Rice, Hassane Soilihi, Aurélien de Reynies, Saverio Minucci, Hugues de Thé. Nat Med 2014
109
15


Arsenic degrades PML or PML-RARalpha through a SUMO-triggered RNF4/ubiquitin-mediated pathway.
Valérie Lallemand-Breitenbach, Marion Jeanne, Shirine Benhenda, Rihab Nasr, Ming Lei, Laurent Peres, Jun Zhou, Jun Zhu, Brian Raught, Hugues de Thé. Nat Cell Biol 2008
509
14

Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation.
Rihab Nasr, Marie-Claude Guillemin, Omar Ferhi, Hassan Soilihi, Laurent Peres, Caroline Berthier, Philippe Rousselot, Macarena Robledo-Sarmiento, Valérie Lallemand-Breitenbach, Bernard Gourmel,[...]. Nat Med 2008
258
12


Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial.
Alan K Burnett, Nigel H Russell, Robert K Hills, David Bowen, Jonathan Kell, Steve Knapper, Yvonne G Morgan, Jennie Lok, Angela Grech, Gail Jones,[...]. Lancet Oncol 2015
247
12

Acute Promyelocytic Leukemia: A Paradigm for Oncoprotein-Targeted Cure.
Hugues de Thé, Pier Paolo Pandolfi, Zhu Chen. Cancer Cell 2017
102
12

PML nuclear bodies.
Valérie Lallemand-Breitenbach, Hugues de Thé. Cold Spring Harb Perspect Biol 2010
358
11


Mutations affecting both the rearranged and the unrearranged PML alleles in refractory acute promyelocytic leukaemia.
Licia Iaccarino, Tiziana Ottone, Mariadomenica Divona, Laura Cicconi, Roberto Cairoli, Maria Teresa Voso, Francesco Lo-Coco. Br J Haematol 2016
15
60

Treatment-influenced associations of PML-RARα mutations, FLT3 mutations, and additional chromosome abnormalities in relapsed acute promyelocytic leukemia.
Robert E Gallagher, Barry K Moser, Janis Racevskis, Xavier Poiré, Clara D Bloomfield, Andrew J Carroll, Rhett P Ketterling, Diane Roulston, Esther Schachter-Tokarz, Da-Cheng Zhou,[...]. Blood 2012
35
22

Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: long-term follow-up data.
Vikram Mathews, Biju George, Ezhilarasi Chendamarai, Kavitha M Lakshmi, Salamun Desire, Poonkuzhali Balasubramanian, Auro Viswabandya, Rajashekar Thirugnanam, Aby Abraham, Ramachandran Velayudhan Shaji,[...]. J Clin Oncol 2010
178
10

The cell biology of disease: Acute promyelocytic leukemia, arsenic, and PML bodies.
Hugues de Thé, Morgane Le Bras, Valérie Lallemand-Breitenbach. J Cell Biol 2012
141
10

Evaluating frequency of PML-RARA mutations and conferring resistance to arsenic trioxide-based therapy in relapsed acute promyelocytic leukemia patients.
Yinjun Lou, Yafang Ma, Jianai Sun, Xiujin Ye, Hanzhang Pan, Yungui Wang, Wenbin Qian, Haitao Meng, Wenyuan Mai, JingSong He,[...]. Ann Hematol 2015
23
34

Retinoic acid and arsenic synergize to eradicate leukemic cells in a mouse model of acute promyelocytic leukemia.
V Lallemand-Breitenbach, M C Guillemin, A Janin, M T Daniel, L Degos, S C Kogan, J M Bishop, H de Thé. J Exp Med 1999
236
9

ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.
Robert C Green, Jonathan S Berg, Wayne W Grody, Sarah S Kalia, Bruce R Korf, Christa L Martin, Amy L McGuire, Robert L Nussbaum, Julianne M O'Daniel, Kelly E Ormond,[...]. Genet Med 2013
9

The origin and evolution of mutations in acute myeloid leukemia.
John S Welch, Timothy J Ley, Daniel C Link, Christopher A Miller, David E Larson, Daniel C Koboldt, Lukas D Wartman, Tamara L Lamprecht, Fulu Liu, Jun Xia,[...]. Cell 2012
9

Comparison of newly diagnosed and relapsed patients with acute promyelocytic leukemia treated with arsenic trioxide: insight into mechanisms of resistance.
Ezhilarasi Chendamarai, Saravanan Ganesan, Ansu Abu Alex, Vandana Kamath, Sukesh C Nair, Arun Jose Nellickal, Nancy Beryl Janet, Vivi Srivastava, Kavitha M Lakshmi, Auro Viswabandya,[...]. PLoS One 2015
32
21

Phase II study of single-agent arsenic trioxide for the front-line therapy of acute promyelocytic leukemia.
Ardeshir Ghavamzadeh, Kamran Alimoghaddam, Shahrbano Rostami, Seyed Hamidolah Ghaffari, Mohamad Jahani, Massoud Iravani, Seyed Asadollah Mousavi, Babak Bahar, Mahdi Jalili. J Clin Oncol 2011
153
9

Retinoic acid induces proteasome-dependent degradation of retinoic acid receptor alpha (RARalpha) and oncogenic RARalpha fusion proteins.
J Zhu, M Gianni, E Kopf, N Honoré, M Chelbi-Alix, M Koken, F Quignon, C Rochette-Egly, H de Thé. Proc Natl Acad Sci U S A 1999
269
9

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
Sue Richards, Nazneen Aziz, Sherri Bale, David Bick, Soma Das, Julie Gastier-Foster, Wayne W Grody, Madhuri Hegde, Elaine Lyon, Elaine Spector,[...]. Genet Med 2015
9

Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemia.
V Madan, P Shyamsunder, L Han, A Mayakonda, Y Nagata, J Sundaresan, D Kanojia, K Yoshida, S Ganesan, N Hattori,[...]. Leukemia 2016
51
13

Uncoupling RARA transcriptional activation and degradation clarifies the bases for APL response to therapies.
Julien Ablain, Magdalena Leiva, Laurent Peres, Julien Fonsart, Elodie Anthony, Hugues de Thé. J Exp Med 2013
58
10

Clearance of PML/RARA-bound promoters suffice to initiate APL differentiation.
Adeline Vitaliano-Prunier, Juliane Halftermeyer, Julien Ablain, Aurélien de Reynies, Laurent Peres, Morgane Le Bras, Daniel Metzger, Hugues de Thé. Blood 2014
19
31

All-trans retinoic acid/As2O3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia.
Zhi-Xiang Shen, Zhan-Zhong Shi, Jing Fang, Bai-Wei Gu, Jun-Min Li, Yong-Mei Zhu, Jing-Yi Shi, Pei-Zheng Zheng, Hua Yan, Yuan-Fang Liu,[...]. Proc Natl Acad Sci U S A 2004
424
7

Molecular findings among patients referred for clinical whole-exome sequencing.
Yaping Yang, Donna M Muzny, Fan Xia, Zhiyv Niu, Richard Person, Yan Ding, Patricia Ward, Alicia Braxton, Min Wang, Christian Buhay,[...]. JAMA 2014
809
7

Clinical whole-exome sequencing for the diagnosis of mendelian disorders.
Yaping Yang, Donna M Muzny, Jeffrey G Reid, Matthew N Bainbridge, Alecia Willis, Patricia A Ward, Alicia Braxton, Joke Beuten, Fan Xia, Zhiyv Niu,[...]. N Engl J Med 2013
7

Long-term efficacy and safety of all-trans retinoic acid/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemia.
Jiong Hu, Yuan-Fang Liu, Chuan-Feng Wu, Fang Xu, Zhi-Xiang Shen, Yong-Mei Zhu, Jun-Min Li, Wei Tang, Wei-Li Zhao, Wen Wu,[...]. Proc Natl Acad Sci U S A 2009
306
7


PML regulates p53 acetylation and premature senescence induced by oncogenic Ras.
M Pearson, R Carbone, C Sebastiani, M Cioce, M Fagioli, S Saito, Y Higashimoto, E Appella, S Minucci, P P Pandolfi,[...]. Nature 2000
645
7


PML-RARalpha/RXR Alters the Epigenetic Landscape in Acute Promyelocytic Leukemia.
Joost H A Martens, Arie B Brinkman, Femke Simmer, Kees-Jan Francoijs, Angela Nebbioso, Felicetto Ferrara, Lucia Altucci, Hendrik G Stunnenberg. Cancer Cell 2010
206
7

Arsenic-induced PML targeting onto nuclear bodies: implications for the treatment of acute promyelocytic leukemia.
J Zhu, M H Koken, F Quignon, M K Chelbi-Alix, L Degos, Z Y Wang, Z Chen, H de Thé. Proc Natl Acad Sci U S A 1997
351
7

Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor alpha degradation.
V Lallemand-Breitenbach, J Zhu, F Puvion, M Koken, N Honoré, A Doubeikovsky, E Duprez, P P Pandolfi, E Puvion, P Freemont,[...]. J Exp Med 2001
392
7

Autophagy contributes to therapy-induced degradation of the PML/RARA oncoprotein.
Pauline Isakson, Magnar Bjørås, Stig Ove Bøe, Anne Simonsen. Blood 2010
191
7

Targeted Therapy Alone for Acute Promyelocytic Leukemia.
Francesco Lo-Coco, Laura Di Donato, Richard F Schlenk. N Engl J Med 2016
35
17

Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): I. As2O3 exerts dose-dependent dual effects on APL cells.
G Q Chen, X G Shi, W Tang, S M Xiong, J Zhu, X Cai, Z G Han, J H Ni, G Y Shi, P M Jia,[...]. Blood 1997
675
7

Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia.
F Grignani, S De Matteis, C Nervi, L Tomassoni, V Gelmetti, M Cioce, M Fanelli, M Ruthardt, F F Ferrara, I Zamir,[...]. Nature 1998
866
7

Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing.
Li Ding, Timothy J Ley, David E Larson, Christopher A Miller, Daniel C Koboldt, John S Welch, Julie K Ritchey, Margaret A Young, Tamara Lamprecht, Michael D McLellan,[...]. Nature 2012
6

GINA, genetic discrimination, and genomic medicine.
Robert C Green, Denise Lautenbach, Amy L McGuire. N Engl J Med 2015
98
6


Impairment of p53 acetylation, stability and function by an oncogenic transcription factor.
Alessandra Insinga, Silvia Monestiroli, Simona Ronzoni, Roberta Carbone, Mark Pearson, Giancarlo Pruneri, Giuseppe Viale, Ettore Appella, PierGiuseppe Pelicci, Saverio Minucci. EMBO J 2004
94
6

The self-association coiled-coil domain of PML is sufficient for the oncogenic conversion of the retinoic acid receptor (RAR) alpha.
M Occhionorelli, F Santoro, I Pallavicini, A Gruszka, S Moretti, D Bossi, A Viale, D Shing, S Ronzoni, I Muradore,[...]. Leukemia 2011
16
31


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.